Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 350 of 517 entries
View as:
SHR-1210 Combined With Apatinib in Treatment of ED-SCLC After Failure of First Line Standard Therapy
Phase: N/A
Priority: Normal
Start: 04/20/18
End: 08/04/21
Due: 08/04/22
Phase: N/A
Priority: Normal
Start: 08/01/22
End: 11/30/22
Due: 11/30/23
Phase: N/A
Priority: Normal
Start: 04/30/14
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 12/20/21
End: 06/30/22
Due: 06/30/23
Phase: N/A
Priority: Normal
Start: 06/04/19
End: 02/09/21
Due: 02/09/22
Phase: N/A
Priority: Normal
Start: 06/10/19
End: 06/14/23
Due: 06/14/24
Phase: N/A
Priority: Normal
Start: 05/31/20
End: 09/10/21
Due: 09/10/22
Phase: N/A
Priority: Normal
Start: 12/06/21
End: 12/31/23
Due: 12/31/24
Phase: N/A
Priority: Normal
Start: 01/31/21
End: 10/31/22
Due: 10/31/23
Phase: N/A
Priority: Normal
Start: 11/09/19
End: 12/30/20
Due: 12/30/21
Phase: N/A
Priority: Normal
Start: 07/19/19
End: 09/12/19
Due: 09/12/20
Phase: N/A
Priority: Normal
Start: 12/31/14
End: 06/30/20
Due: 06/30/21
Phase: N/A
Priority: Normal
Start: 05/03/21
End: 09/24/21
Due: 09/24/22
Phase: N/A
Priority: Normal
Start: 07/05/24
End: 08/31/26
Due: 08/31/27
Phase: N/A
Priority: Normal
Start: 09/01/20
End: 08/31/21
Due: 08/31/22
Phase: N/A
Priority: Normal
Start: 08/31/24
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 09/30/21
End: 02/29/24
Due: 02/28/25
Phase: N/A
Priority: Normal
Start: 06/30/23
End: 06/30/26
Due: 06/30/27
Phase: N/A
Priority: Normal
Start: 09/30/14
End: 08/31/17
Due: 08/31/18
Phase: N/A
Priority: Normal
Start: 04/27/16
End: 05/06/19
Due: 05/06/20
Phase: N/A
Priority: Normal
Start: 05/27/20
End: 07/18/20
Due: 07/18/21
Safety and Efficacy Study of Famitinib in Patients With Advanced Colorectal Adenocarcinoma（FACT）
Phase: N/A
Priority: Normal
Start: 01/31/15
End: 07/31/19
Due: 07/31/20
Phase: N/A
Priority: Normal
Start: 07/31/11
End: 08/31/16
Due: 08/31/17
Phase: N/A
Priority: Normal
Start: 07/31/13
End: 05/31/14
Due: 05/31/15
Phase: N/A
Priority: Normal
Start: 02/28/15
End: -
Due: -